(Q40614121)
Statements
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination (English)
Ignacio Melero
Noelia Casares
Francisco Borrás-Cuesta
Laura Arribillaga
Ascensión Lopez-Diaz de Cerio
Jesús Prieto
1 December 2003